Year |
Citation |
Score |
2014 |
Colletti JA, Leland-Wavrin KM, Kurz SG, Hickman MP, Seiler NL, Samanas NB, Eckert QA, Dennison KL, Ding L, Schaffer BS, Shull JD. Validation of six genetic determinants of susceptibility to estrogen-induced mammary cancer in the rat and assessment of their relevance to breast cancer risk in humans. G3 (Bethesda, Md.). 4: 1385-94. PMID 24875630 DOI: 10.1534/G3.114.011163 |
0.405 |
|
2013 |
Schaffer BS, Leland-Wavrin KM, Kurz SG, Colletti JA, Seiler NL, Warren CL, Shull JD. Mapping of three genetic determinants of susceptibility to estrogen-induced mammary cancer within the Emca8 locus on rat chromosome 5. Cancer Prevention Research (Philadelphia, Pa.). 6: 59-69. PMID 23151807 DOI: 10.1158/1940-6207.Capr-12-0346-T |
0.434 |
|
2008 |
Kurz SG, Hansen KK, McLaughlin MT, Shivaswamy V, Schaffer BS, Gould KA, McComb RD, Meza JL, Shull JD. Tissue-specific actions of the Ept1, Ept2, Ept6, and Ept9 genetic determinants of responsiveness to estrogens in the female rat. Endocrinology. 149: 3850-9. PMID 18420736 DOI: 10.1210/En.2008-0173 |
0.396 |
|
2007 |
Shull JD, Lachel CM, Murrin CR, Pennington KL, Schaffer BS, Strecker TE, Gould KA. Genetic control of estrogen action in the rat: mapping of QTLs that impact pituitary lactotroph hyperplasia in a BN x ACI intercross. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 18: 657-69. PMID 17876666 DOI: 10.1007/S00335-007-9052-2 |
0.437 |
|
2007 |
Adamovic T, Roshani L, Chen L, Schaffer BS, Helou K, Levan G, Olsson B, Shull JD. Nonrandom pattern of chromosome aberrations in 17beta-estradiol-induced rat mammary tumors: indications of distinct pathways for tumor development. Genes, Chromosomes & Cancer. 46: 459-69. PMID 17285573 DOI: 10.1002/Gcc.20428 |
0.403 |
|
2006 |
Schaffer BS, Lachel CM, Pennington KL, Murrin CR, Strecker TE, Tochacek M, Gould KA, Meza JL, McComb RD, Shull JD. Genetic bases of estrogen-induced tumorigenesis in the rat: mapping of loci controlling susceptibility to mammary cancer in a Brown Norway x ACI intercross. Cancer Research. 66: 7793-800. PMID 16885383 DOI: 10.1158/0008-5472.Can-06-0143 |
0.459 |
|
2006 |
Shull JD, Lachel CM, Strecker TE, Spady TJ, Tochacek M, Pennington KL, Murrin CR, Meza JL, Schaffer BS, Flood LA, Gould KA. Genetic bases of renal agenesis in the ACI rat: mapping of Renag1 to chromosome 14. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 17: 751-9. PMID 16845468 DOI: 10.1007/S00335-006-0004-Z |
0.316 |
|
2005 |
Gould KA, Pandey J, Lachel CM, Murrin CR, Flood LA, Pennington KL, Schaffer BS, Tochacek M, McComb RD, Meza JL, Wendell DL, Shull JD. Genetic mapping of Eutr1, a locus controlling E2-induced pyometritis in the Brown Norway rat, to RNO5. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 16: 854-64. PMID 16284801 DOI: 10.1007/S00335-005-0070-7 |
0.393 |
|
2005 |
Strecker TE, Spady TJ, Schaffer BS, Gould KA, Kaufman AE, Shen F, McLaughlin MT, Pennington KL, Meza JL, Shull JD. Genetic bases of estrogen-induced pituitary tumorigenesis: identification of genetic loci determining estrogen-induced pituitary growth in reciprocal crosses between the ACI and Copenhagen rat strains. Genetics. 169: 2189-97. PMID 15687265 DOI: 10.1534/Genetics.104.039370 |
0.4 |
|
2004 |
Gould KA, Tochacek M, Schaffer BS, Reindl TM, Murrin CR, Lachel CM, VanderWoude EA, Pennington KL, Flood LA, Bynote KK, Meza JL, Newton MA, Shull JD. Genetic determination of susceptibility to estrogen-induced mammary cancer in the ACI rat: mapping of Emca1 and Emca2 to chromosomes 5 and 18. Genetics. 168: 2113-25. PMID 15611180 DOI: 10.1534/Genetics.104.033878 |
0.436 |
|
2003 |
Schaffer BS, Lin MF, Byrd JC, Park JH, MacDonald RG. Opposing roles for the insulin-like growth factor (IGF)-II and mannose 6-phosphate (Man-6-P) binding activities of the IGF-II/Man-6-P receptor in the growth of prostate cancer cells. Endocrinology. 144: 955-66. PMID 12586773 DOI: 10.1210/En.2002-220751 |
0.629 |
|
2003 |
Shull J, Schaffer B, Bartsch L, Buckles L, Gould K, Tochacek M, Xie B, Lachel C, Pennington K, Strecker T, Hansen K. Genetic determinants of susceptibility to estrogen-induced mammary cancer in the rat Breast Cancer Research. 5: 32-32. DOI: 10.1186/Bcr691 |
0.6 |
|
2002 |
Corkins MR, McQuade J, Schaffer BS, MacDonald RG. Insulin-like growth factor binding protein-4 expression is dependent on the carbohydrate in the media in HT-29 cells. Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. 12: 184-92. PMID 12163000 DOI: 10.1016/S1096-6374(02)00041-2 |
0.62 |
|
2002 |
Kim EJ, Schaffer BS, Kang YH, Macdonald RG, Park JH. Decreased production of insulin-like growth factor-binding protein (IGFBP)-6 by transfection of colon cancer cells with an antisense IGFBP-6 cDNA construct leads to stimulation of cell proliferation. Journal of Gastroenterology and Hepatology. 17: 563-70. PMID 12084030 DOI: 10.1046/J.1440-1746.2002.02703.X |
0.631 |
|
2002 |
Kim EJ, Kang YH, Schaffer BS, Bach LA, MacDonald RG, Park JH. Inhibition of Caco-2 cell proliferation by all-trans retinoic acid: role of insulin-like growth factor binding protein-6. Journal of Cellular Physiology. 190: 92-100. PMID 11807815 DOI: 10.1002/Jcp.10045 |
0.635 |
|
2001 |
Oh YS, Kim EJ, Schaffer BS, Kang YH, Binderup L, MacDonald RG, Park JH. Synthetic low-calcaemic vitamin D(3) analogues inhibit secretion of insulin-like growth factor II and stimulate production of insulin-like growth factor-binding protein-6 in conjunction with growth suppression of HT-29 colon cancer cells. Molecular and Cellular Endocrinology. 183: 141-9. PMID 11604234 DOI: 10.1016/S0303-7207(01)00598-6 |
0.616 |
|
2000 |
Byrd JC, Park JH, Schaffer BS, Garmroudi F, MacDonald RG. Dimerization of the insulin-like growth factor II/mannose 6-phosphate receptor. The Journal of Biological Chemistry. 275: 18647-56. PMID 10764761 DOI: 10.1074/Jbc.M001273200 |
0.548 |
|
2000 |
Corkins MR, Schaffer BS, MacDonald RG. Retinoic acid decreases expression of insulin-like growth factor (IFG)-II by HT-29 cells Gastroenterology. 118: A1065. DOI: 10.1016/S0016-5085(00)80054-2 |
0.58 |
|
1999 |
MacDonald RG, Schaffer BS, Kang IJ, Hong SM, Kim EJ, Park JH. Growth inhibition and differentiation of the human colon carcinoma cell line, Caco-2, by constitutive expression of insulin-like growth factor binding protein-3. Journal of Gastroenterology and Hepatology. 14: 72-8. PMID 10029281 DOI: 10.1046/J.1440-1746.1999.01803.X |
0.63 |
|
1998 |
Corkins MR, Schaffer BS, MacDonald RG. INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN (IGFBP)-4 EXPRESSION IN HT-29 CELLS IS DEPENDENT ON THE CARBOHYDRATE AVAILABLE IN CULTURE MEDIUM Journal of Pediatric Gastroenterology & Nutrition. 27: 474. DOI: 10.1097/00005176-199810000-00065 |
0.587 |
|
1996 |
Garmroudi F, Devi G, Slentz DH, Schaffer BS, MacDonald RG. Truncated forms of the insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor encompassing the IGF-II binding site: characterization of a point mutation that abolishes IGF-II binding. Molecular Endocrinology (Baltimore, Md.). 10: 642-51. PMID 8776724 DOI: 10.1210/Mend.10.6.8776724 |
0.558 |
|
1996 |
Park JH, Corkins MR, Vanderhoof JA, Caruso NM, Hrbek MJ, Schaffer BS, Slentz DH, McCusker RH, MacDonald RG. Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation. Journal of Cellular Physiology. 166: 396-406. PMID 8592000 DOI: 10.1002/(Sici)1097-4652(199602)166:2<396::Aid-Jcp18>3.0.Co;2-9 |
0.609 |
|
Show low-probability matches. |